HealthEquity, Inc. (NASDAQ:HQY) Shares Bought by Premier Fund Managers Ltd

Premier Fund Managers Ltd grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 22.7% during the 4th quarter, HoldingsChannel.com reports. The firm owned 11,076 shares of the company’s stock after buying an additional 2,046 shares during the quarter. Premier Fund Managers Ltd’s holdings in HealthEquity were worth $1,073,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Charles Schwab Investment Management Inc. increased its holdings in shares of HealthEquity by 1.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock valued at $86,909,000 after acquiring an additional 14,532 shares during the period. Raymond James Trust N.A. raised its holdings in shares of HealthEquity by 4.8% in the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after buying an additional 132 shares during the last quarter. Citigroup Inc. boosted its stake in shares of HealthEquity by 73.0% during the third quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock worth $8,357,000 after buying an additional 43,084 shares during the period. Cerity Partners LLC grew its holdings in shares of HealthEquity by 15.1% during the third quarter. Cerity Partners LLC now owns 17,259 shares of the company’s stock worth $1,413,000 after buying an additional 2,258 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its position in HealthEquity by 165.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company’s stock valued at $1,673,000 after acquiring an additional 12,745 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

HQY has been the topic of several analyst reports. Barrington Research reiterated an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. Royal Bank of Canada upped their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 10th. Raymond James raised shares of HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $120.00 to $115.00 in a report on Tuesday. Finally, KeyCorp cut their price target on shares of HealthEquity from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Monday. One research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average target price of $112.23.

HealthEquity Stock Down 0.4 %

HQY opened at $88.83 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The company has a market cap of $7.68 billion, a price-to-earnings ratio of 81.50, a PEG ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59. The business’s fifty day moving average is $103.94 and its two-hundred day moving average is $95.84.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 2.20% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.